Based on Your Reading:
Get Your Free Mesothelioma Guide
Find a Top Mesothelioma Doctor
Access Help Paying for Treatment
Desmoplastic mesothelioma, or DMM, is a cell subtype of malignant mesothelioma. It is sometimes misdiagnosed as pleural fibrosis. Desmoplastic mesothelioma can be characterized by a high concentration of fibrous connective tissue.
Written by Karen Selby, RN • Edited By Walter Pacheco • Medically Reviewed By Dr. Andrea Wolf
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.LashawnMesothelioma patient’s daughter
Selby, K. (2024, February 2). Desmoplastic Mesothelioma. Asbestos.com. Retrieved March 18, 2024, from https://www.asbestos.com/mesothelioma/desmoplastic/
Selby, Karen. "Desmoplastic Mesothelioma." Asbestos.com, 2 Feb 2024, https://www.asbestos.com/mesothelioma/desmoplastic/.
Selby, Karen. "Desmoplastic Mesothelioma." Asbestos.com. Last modified February 2, 2024. https://www.asbestos.com/mesothelioma/desmoplastic/.
Desmoplastic mesothelioma is a subtype of the sarcomatoid form of mesothelioma. Sarcomatoid refers to long and spindle-shaped cells. It is a rarer and more deadly form of mesothelioma cancer.
Dense fibrous tissue and reduced cellular features characterize the desmoplasia variant. This subtype has a poor prognosis and can occur in all types of sarcomatoid mesothelioma.
Desmoplastic cells are not well-differentiated and lack defining qualities or patterns. These types of mesothelioma cells form dense nodules of connective tissue within tumors. This makes diagnosis more challenging.
This rare variation is present in 5% to 10% of all malignant mesothelioma cases. Asbestos exposure is the disease’s primary cause. It can develop in the different types of mesothelioma cancer.
A biopsy of tumor tissue diagnoses desmoplastic mesothelioma. Doctors take a large tissue sample so they can review enough cells to make a diagnosis. When diagnosing mesothelioma, a sample of tumor tissue is essential. It determines the cell type and treatment options.
Fibrous regions of this tumor can hide cell variations that lead to an accurate diagnosis. Physicians sometimes misdiagnose desmoplastic malignant pleural mesothelioma as fibrous pleurisy. Other misdiagnoses include pleural fibrosis, rheumatoid disease or spindle cell sarcoma.
Doctors look for the following characteristics to diagnose desmoplastic mesothelioma:
When desmoplastic mesothelioma spreads to other areas, it can look bland. This causes doctors to mistake the cells as benign fibrous tissue. Imaging scans such as a CT or MRI may help pathologists identify metastasis and diagnose DMM in challenging cases.
In 2017, pathology researchers discovered a protein called GATA-3. It differentiates desmoplastic mesothelioma from sarcomatoid lung cancer. It is present in many mesothelioma cases and often absent in lung carcinoma cases. This factor aids physicians when staging pleural mesothelioma.
Get Your Free Mesothelioma Guide
Find a Top Mesothelioma Doctor
Access Help Paying for Treatment
Dense and fibrous areas may produce symptoms like pulmonary fibrosis, such as chest pain and a buildup of fluid in the lungs. But, these symptoms develop in every case of mesothelioma.
The tumor’s cell type doesn’t affect symptoms of mesothelioma. Pleural mesothelioma patients experience shortness of breath. Peritoneal patients often present with abdominal pain.
The treatment options for desmoplastic mesothelioma include immunotherapy, chemotherapy and radiation therapy. These can kill cancerous cells to shrink tumors and limit spreading. Treatment depends on the patient’s age and health.
Immunotherapy with nivolumab (Opdivo) and ipilimumab (Yervoy) is the first-line treatment. Chemotherapy with cisplatin and pemetrexed (Alimta) follows. Radiation can shrink painful chest wall tumors.
This type of mesothelioma is not treated with surgery. It has a high risk of returning within several months. It is rare for a surgeon to recommend it to desmoplastic patients. A few case reports show some patients lived several months longer following surgery. They were desmoplastic patients with early-stage or localized tumors.
Treatments aim to reduce symptoms, prolong survival and improve quality of life. Doctors recommend pleurodesis or paracentesis to remove fluid from the lungs or abdomen.
The prognosis of mesothelioma with desmoplasia is not favorable. It resembles other types of sarcomatoid cancer. The disease subtype is tricky to diagnose. Patients often have advanced disease at diagnosis. The life expectancy of patients with this subtype is less than one year.
A seven-year study evaluated 255 patients with mesothelioma between 1982 and 1989. Researchers identified 17 cases of the desmoplastic subtype. Of those, 11 were sarcomatoid and six were biphasic, comprising both sarcomatoid and epithelial cell types.
The mean survival from the onset of symptoms to death was 5.8 months for the sarcomatoid variant and 6.8 months for the biphasic variant. Other studies show an average life expectancy of 3.8 months.
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592